My Treatment Approach: NSCLC Testing and Management of Complex Cases

Experts discuss complex hypothetical patient case scenarios in non–small cell lung cancer (NSCLC), highlighting current screening and testing methodologies, diagnostic challenges, and best practices in management.

EP. 1: My Treatment Approach: NSCLC Testing and Management of Complex Cases

November 24th 2025

Two expert oncologists discuss the critical role of comprehensive biomarker testing in non-small cell lung cancer (NSCLC). They emphasize that molecular testing is an essential part of the initial diagnosis, not an optional add-on, as it identifies specific mutations and fusions that dictate the most effective first-line treatment.

EP. 2: Tissue is Critical: Best Practices for NSCLC Biomarker Testing

November 24th 2025

The oncologists delve into the specifics of which non-small cell lung cancer (NSCLC) patients to test. They recommend testing all non-squamous cases and, increasingly, squamous cases as well, especially those with a light smoking history, to ensure no actionable biomarker is missed.

EP. 3: NSCLC Case Study 1: Staging & Diagnostic Workup for a Lung Nodule

December 1st 2025

The oncologists delve into the specifics of which non-small cell lung cancer (NSCLC) patients to test. They recommend testing all non-squamous cases and, increasingly, squamous cases as well, especially those with a light smoking history, to ensure no actionable biomarker is missed.

EP. 4: NSCLC Case Study 1: Essential Molecular Testing for New Lung Cancer Diagnosis

December 1st 2025

The oncologists delve into the specifics of which non-small cell lung cancer (NSCLC) patients to test. They recommend testing all non-squamous cases and, increasingly, squamous cases as well, especially those with a light smoking history, to ensure no actionable biomarker is missed.